Tg(Ins1-RFP,-cre/ERT2)23Narl
Transgene Detail
|
|
| Symbol: |
Tg(Ins1-RFP,-cre/ERT2)23Narl |
| Name: |
Transgene insertion 23, National Applied Research Laboratories |
| MGI ID: |
MGI:5898245 |
| Transgene: |
Tg(Ins1-RFP,-cre/ERT2)23Narl Location: unknown
|
| Alliance: |
Tg(Ins1-RFP,-cre/ERT2)23Narl page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(Ins1-RFP,-cre/ERT2)23Narl expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| mouse |
Ins1 (MGI:96572) |
|
|
| |
|
Mutation details: The construct containing mouse insulin I (Ins1) promoter driving Red Fluorescent Protein (RFP) and cre/ERT2 fusion gene was used to create transgenic line in C57BL/6 mouse. Cre recombinase is activated in the pancreas, eyes, renal pelvis, and adrenal glands after tamoxifen induction.
(J:202955)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Ins1
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:202955 National Laboratory Animal Center, et al., Transgene insertion mice at National Laboratory Animal Center, National Applied Research Laboratories. MGI Direct Data Submission. 2013-2017; |
| All: |
1 reference(s) |
|
Analysis Tools
